Free Trial

Genflow Biosciences (GENF) Competitors

GBX 0.70 0.00 (-0.29%)
As of 08/1/2025 11:50 AM Eastern

GENF vs. OBD, SNG, IMM, BVX, FAB, APTA, CIZ, HEMO, EVG, and MTFB

Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include Oxford BioDynamics (OBD), Synairgen (SNG), ImmuPharma (IMM), BiVictriX Therapeutics (BVX), Fusion Antibodies (FAB), Aptamer Group (APTA), Cizzle Biotechnology (CIZ), Hemogenyx Pharmaceuticals (HEMO), Evgen Pharma (EVG), and Motif Bio (MTFB). These companies are all part of the "biotechnology" industry.

Genflow Biosciences vs. Its Competitors

Genflow Biosciences (LON:GENF) and Oxford BioDynamics (LON:OBD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

Genflow Biosciences has higher earnings, but lower revenue than Oxford BioDynamics. Genflow Biosciences is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genflow Biosciences-£226.19K-10.52-£1.76M-£0.53-1.32
Oxford BioDynamics£5.75M1.89-£103.52M-£5.70-0.10

Genflow Biosciences has a beta of 2.37, suggesting that its share price is 137% more volatile than the S&P 500. Comparatively, Oxford BioDynamics has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500.

9.2% of Genflow Biosciences shares are owned by institutional investors. Comparatively, 44.3% of Oxford BioDynamics shares are owned by institutional investors. 64.2% of Genflow Biosciences shares are owned by insiders. Comparatively, 16.8% of Oxford BioDynamics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Genflow Biosciences has a net margin of 778.46% compared to Oxford BioDynamics' net margin of -1,800.32%. Genflow Biosciences' return on equity of -208.12% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Genflow Biosciences778.46% -208.12% -58.66%
Oxford BioDynamics -1,800.32%-289.38%-56.23%

In the previous week, Genflow Biosciences' average media sentiment score of 0.00 equaled Oxford BioDynamics'average media sentiment score.

Company Overall Sentiment
Genflow Biosciences Neutral
Oxford BioDynamics Neutral

Summary

Genflow Biosciences beats Oxford BioDynamics on 6 of the 11 factors compared between the two stocks.

Get Genflow Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GENF vs. The Competition

MetricGenflow BiosciencesBiotechnology IndustryMedical SectorLON Exchange
Market Cap£2.38M£134.75M£5.53B£3.03B
Dividend YieldN/A3.74%4.74%5.02%
P/E Ratio-1.323.8028.95176.75
Price / Sales-10.524,246.60443.41264,362.45
Price / Cash3.0013.1924.4827.97
Price / Book2.8139.388.364.53
Net Income-£1.76M-£90.99M£3.25B£5.90B
7 Day Performance-14.88%-2.28%-3.55%12.58%
1 Month Performance-2.92%3.50%5.11%4.64%
1 Year Performance-69.65%186.10%25.34%73.45%

Genflow Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GENF
Genflow Biosciences
N/AGBX 0.70
-0.3%
N/A-69.7%£2.38M-£226.19K-1.325Gap Up
OBD
Oxford BioDynamics
N/AGBX 0.52
flat
N/A-91.6%£9.71M£5.75M-0.0945
SNG
Synairgen
N/AN/AN/AN/A£9.04MN/A-0.5634Gap Down
IMM
ImmuPharma
N/AGBX 2.12
+1.4%
N/A+22.5%£9.01M-£71.31K-3.6713Gap Up
BVX
BiVictriX Therapeutics
N/AN/AN/AN/A£8.25MN/A-250.0017Gap Up
High Trading Volume
FAB
Fusion Antibodies
N/AGBX 8.50
-5.8%
N/A+271.1%£8.00M£2.09M-1.9148News Coverage
APTA
Aptamer Group
N/AGBX 0.35
-3.8%
N/A+52.3%£6.98M£4.12M-0.4937Gap Down
CIZ
Cizzle Biotechnology
N/AGBX 1.64
+2.5%
N/A-22.7%£6.46MN/A-2,288.584Gap Up
HEMO
Hemogenyx Pharmaceuticals
N/AGBX 179.36
+0.8%
N/A+12,173.7%£6.39MN/A-917.5314Gap Up
EVG
Evgen Pharma
N/AN/AN/AN/A£3.42MN/A-80.0010
MTFB
Motif Bio
N/AN/AN/AN/A£3.28MN/A-0.036

Related Companies and Tools


This page (LON:GENF) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners